CCRN Shareholders Set to Receive 31% Premium in $437 Million Takeover by Knox Lane
Definitive Agreement Offers Immediate Value for Investors
Cross Country Healthcare (NASDAQ: CCRN), a leader in technology-driven healthcare workforce solutions, announced a definitive agreement to be acquired by investment firm Knox Lane in an all-cash transaction valued at $437 million. The deal offers $13.25 per share to CCRN stockholders, representing a substantial 31% premium over the company’s May 6, 2026 closing price—and a 45% premium over its 90-day volume-weighted average price.
Privatization Marks a Turning Point for Cross Country Healthcare
This transaction marks an inflection point for Cross Country Healthcare, which will move from public to private ownership as part of Knox Lane’s portfolio. The move signals confidence in CCRN’s ability to leverage its proprietary technology and AI-driven labor analytics platform, a foundation built on four decades in the healthcare labor industry.
Deal Terms and Shareholder Impact Highlighted
Here’s a summary of deal highlights and investor takeaways:
| Buyer | Value per Share | Total Deal Value | Premium to Last Close | Premium to 90-day VWAP | Expected Closing |
|---|---|---|---|---|---|
| Knox Lane | $13.25 | $437 million | 31% | 45% | Q3 2026 |
Strategic Rationale: Technology, Analytics, and Sector Expertise
Leadership from both CCRN and Knox Lane emphasize the combined push toward advanced technology and workforce analytics. The Intellify® platform, already central to CCRN’s value proposition, is expected to benefit from Knox Lane’s expertise in digital transformation and business scaling strategies. The board and two investment teams expect this partnership to drive growth while supporting clients and healthcare professionals.
Next Steps: Shareholder and Regulatory Approvals Pending
The acquisition is expected to close in the third quarter of 2026, subject to standard closing conditions—most notably, shareholder and regulatory approvals. Following the transaction, CCRN will continue to operate under its established name and brand, but stockholders will no longer have public market exposure, as its Nasdaq listing is set to end upon completion.
Key Takeaway: Shareholders Gain While CCRN Prepares for a New Growth Chapter
For investors, the all-cash nature of the deal reduces uncertainty and establishes a clear exit at a notable premium. At an enterprise value that reflects both CCRN’s sector leadership and forward growth prospects, the move to private ownership signals confidence in the durability and scalability of CCRN’s technology-driven model. Those holding CCRN shares ahead of the record date can expect further communications regarding the shareholder meeting and payout procedures as the approval process unfolds.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI